ARCHIVES

Erbitux Plus Chemo Effective For NSCLC; Carboplatin Prevents Testicular Recurrence

This article is from The Cancer Letter archive.

Vol. 31 No. 7 | July 25, 2008

Download PDF Visit The Full Archive

Related Articles

European regulators plan more rigorous rules for accelerated approval in cancer.

November 11, 2005

The Cancer Letter takes two-week break; next issue Jan. 2.

December 12, 2003

Upton Says NCI Must Take “Vigorous Role” In Prevention

February 3, 1978

Complete List of Recommendations by Centers Committee

October 18, 1996

New Grants Awarded In Tobacco Research

February 17, 1978

Schmidt Already Working For NIH Despite His Opposition To Kennedy’s New Research Panel

April 5, 1974